NCT04348929

Brief Summary

Different studies have demonstrated that the absence of companionship during labor and childbirth may be responsible for a negative birth experience, an increased risk of postnatal depression and/or post traumatic stress disorders. These situation may also have a negative impact on mother-child interaction, on marital and family relationship and on the rate of maternal suicide in postpartum. However, these previous results cannot be extrapolated in the current context where the absence of the companionship is imposed by the confinement framework. The objective of the CONFINE study is to assess, for the first time, the birth experience of women in the context of limited social support in the immediate post-partum period due to confinement, as well as the associated over-risk of mental disorders, compared to a post-partum without social restriction.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
927

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 10, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

April 16, 2020

Completed
Same day until next milestone

Study Start

First participant enrolled

April 16, 2020

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 21, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 21, 2023

Completed
Last Updated

February 8, 2024

Status Verified

February 1, 2024

Enrollment Period

3.3 years

First QC Date

April 10, 2020

Last Update Submit

February 7, 2024

Conditions

Keywords

confinementbirth experiencecovid-19

Outcome Measures

Primary Outcomes (1)

  • "Labor Agentry Scale questionnaire" score in immediate post-partum (duration of hospital stay)

    through study completion, an average of 16 months

Secondary Outcomes (7)

  • "Labor Agentry Scale questionnaire" score at two months after birth

    through study completion, an average of 16 months

  • Edinburg Postnatale Depression Scale questionnaire" score at two months after birth

    through study completion, an average of 16 months

  • "Impact of Event Scale - Revised questionnaire" score at two months after birth

    through study completion, an average of 16 months

  • Breastfeeding statement at two months after birth

    through study completion, an average of 16 months

  • "SF-12 Quality of life questionnaire" score at two months after birth

    through study completion, an average of 16 months

  • +2 more secondary outcomes

Study Arms (3)

Confinement group

EXPERIMENTAL

Delivery during covid-19 confinement period

Other: Self-administered questionnaires

Control group

OTHER

Delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)

Other: Self-administered questionnaires

Epidemic group

OTHER

Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)

Other: Self-administered questionnaires

Interventions

Self-administered questionnaires once during the post-natal hospitalization and a second time 7 to 9 weeks after the delivery (at home)

Confinement groupControl groupEpidemic group

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Woman who is \>= 18 years old
  • Woman having just given birth from 37 weeks of gestation (singleton pregnancy)
  • Woman affiliated to a social security
  • Woman with a level of understanding of written French sufficient to answer the questionnaires.
  • Woman having received complete information on the organization of the research and having given her informed consent in written form.
  • For "epidemic" group: Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)
  • For "control" group: Start of pregnancy after confinement and delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)

You may not qualify if:

  • Major mentioned in articles L.1121-6 and L-1121-8 of Health Public Code.
  • Woman with psychiatric disorders such as depressive syndrome
  • Woman considered positive for covid-19 and treated as such at the time of delivery (regardless of test result)
  • Newborn with congenital abnormalities
  • Stillbirth

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Centre Hospitalier Régional Universitaire de Nancy

Nancy, 54000, France

Location

Related Publications (1)

  • Bertholdt C, Epstein J, Banasiak C, Ligier F, Dahlhoff S, Olieric MF, Mottet N, Beaumont M, Morel O. Birth experience during COVID-19 confinement (CONFINE): protocol for a multicentre prospective study. BMJ Open. 2020 Dec 10;10(12):e043057. doi: 10.1136/bmjopen-2020-043057.

MeSH Terms

Conditions

Depression, PostpartumCOVID-19

Condition Hierarchy (Ancestors)

Puerperal DisordersPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesDepressive DisorderMood DisordersMental DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Charline BERTHOLDT

    Central Hospital, Nancy, France

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator (obstetrician-gynecologist)

Study Record Dates

First Submitted

April 10, 2020

First Posted

April 16, 2020

Study Start

April 16, 2020

Primary Completion

July 21, 2023

Study Completion

July 21, 2023

Last Updated

February 8, 2024

Record last verified: 2024-02

Data Sharing

IPD Sharing
Will share

All data generated during this study will be made available via CIC-EC, CHRU Nancy, Nancy- FRANCE in accordance with protocol promotor. Data obtained from this study will be deposited at CIC-EC Nancy where they will be maintained for a minimum of 15 years.

Locations